latanoprost + timolol vir 0.05 mg/ml + 5 mg/ml colírio, solução
laboratórios vir portugal, lda. - latanoprost + timolol - colírio, solução - 0.05 mg/ml + 5 mg/ml - latanoprost 0.05 mg/ml ; timolol, maleato 6.8 mg/ml - timolol, combinations - n/a - duração do tratamento: longa duração
latanoprost + timolol vir 0.05 mg/ml + 5 mg/ml colírio, solução
laboratórios vir portugal, lda. - latanoprost + timolol - colírio, solução - 0.05 mg/ml + 5 mg/ml - latanoprost 0.05 mg/ml ; timolol, maleato 6.8 mg/ml - timolol, combinations - n/a - duração do tratamento: longa duração
comirnaty
biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vacinas - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. o uso desta vacina deve ser de acordo com as recomendações oficiais.
spikevax (previously covid-19 vaccine moderna)
moderna biotech spain, s.l. - single-stranded, 5’-capped messenger rna (mrna) produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vacinas - spikevax is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax bivalent original/omicron ba. 1 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against covid-19. spikevax bivalent original/omicron ba. 4-5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax xbb. 5 is indicated for active immunisation to prevent covid 19 caused by sars-cov-2 in individuals 6 months of age and older. the use of this vaccine should be in accordance with official recommendations.
daxocox
ecuphar nv - enflicoxib - produtos antiinflamatórios e anti-reumáticos - cães - for the treatment of pain and inflammation associated with osteoarthritis (or degenerative joint disease) in dogs.
mepisv
dfl indÚstria e comÉrcio s/a - cloridrato de mepivacaÍna - anestesicos locais
irbesartan + hidroclorotiazida aurovitas 150 mg + 12.5 mg comprimido revestido por película
generis farmacêutica, s.a. - irbesartan + hidroclorotiazida - comprimido revestido por película - 150 mg + 12.5 mg - irbesartan 150 mg ; hidroclorotiazida 12.5 mg - irbesartan and diuretics - genérico - duração do tratamento: longa duração
esomeprazol cipla 20 mg comprimido gastrorresistente
cipla europe, n.v. - esomeprazol - comprimido gastrorresistente - 20 mg - esomeprazol, magnésio di-hidratado 21.75 mg - esomeprazole - genérico - duração do tratamento: longa duração
esomeprazol cipla 20 mg comprimido gastrorresistente
cipla europe, n.v. - esomeprazol - comprimido gastrorresistente - 20 mg - esomeprazol, magnésio di-hidratado 21.75 mg - esomeprazole - genérico - duração do tratamento: longa duração
hidroclorotiazida generis 50 mg comprimido
generis farmacêutica, s.a. - hidroclorotiazida - comprimido - 50 mg - hidroclorotiazida 50 mg - hydrochlorothiazide - n/a - duração do tratamento: longa duração